Genetic analysis of the E2 transactivation domain dimerization interface from bovine papillomavirus type 1

Virology. 2013 May 10;439(2):132-9. doi: 10.1016/j.virol.2013.02.012. Epub 2013 Mar 11.

Abstract

The bovine papillomavirus type 1 (BPV1) E2 protein binds as a dimer to the viral genome to promote its transcription, replication and maintenance in keratinocytes. Although BPV1 E2 dimerizes primarily through its DNA-binding domain, it was shown previously that its transactivation domain (TAD) can also dimerize in vitro through formation of a disulfide bond between cysteine 57 (C57) of adjacent monomers and of an ion pair between arginine 172 (R172) and aspartic acid 175 (D175). The function of this TAD dimerization interface in vivo remains unknown. Here, we report the effects of substituting C57, R172 and D175 by alanine on the transactivation activity of BPV E2 as well as on its ability to support viral DNA replication using a novel luciferase-based assay. Results for this mutational analysis suggest that the TAD dimerization interface is not essential for either process but may contribute to the DNA replication activity of BPV1 E2.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Bovine papillomavirus 1 / genetics
  • Bovine papillomavirus 1 / physiology*
  • DNA Mutational Analysis
  • DNA, Viral / metabolism
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Humans
  • Mutant Proteins / genetics
  • Mutant Proteins / metabolism
  • Protein Multimerization*
  • Viral Proteins / genetics
  • Viral Proteins / metabolism*
  • Virus Replication*

Substances

  • DNA, Viral
  • DNA-Binding Proteins
  • E2 protein, Bovine papillomavirus
  • Mutant Proteins
  • Viral Proteins